Iovance Biotherapeutics, Inc.
Remnant tumor infiltrating lymphocytes and methods of preparing and using the same
Last updated:
Abstract:
In some embodiments, methods of delivering a therapeutically effective amount of an expanded number of tumor infiltrating lymphocytes obtained from tumor remnants to a patient in need thereof, for the treatment of a cancer, are disclosed.
Status:
Grant
Type:
Utility
Filling date:
17 Nov 2017
Issue date:
2 Aug 2022